Extract notice to the Minister

NB-Risedronate

Common name / Subject : risédronate sodique
Name of the manufacturer : NB Pharma
Form : Co.
Dosage : 35 mg

Indication :

INESSS' Recommendation
Inscription

Minister's decisions
Inscrire sur les listes des médicaments (2026-09-24)

Evaluation published on September 09, 2026

Subscribe to our newsletter now

Subscription